News

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, ...
Zacks Small Cap Research on MSN1h
NRXBF Treatment Restores Mobility to Spinal Injury Patients
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
Targeted Oncology7h
FDA Orphan Drug Status Granted for CAR T-Cell Therapy in Malignant Gliomas
FDA designates MB-101 CAR T-cell therapy for glioblastoma, highlighting its potential in treating aggressive brain tumors ...
Data show teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial
Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...